Skip to main content
Journal cover image

First- and third-generation epidermal growth factor receptor inhibitors mediate distinct phosphoprotein signalling networks: implications for adverse dermatological reactions.

Publication ,  Journal Article
Vasavda, C; Ho, BK; Zhang, DY; Williams, KA; Kaffenberger, BH; Kwatra, SG; Kwatra, MM
Published in: Br J Dermatol
December 2020

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Br J Dermatol

DOI

EISSN

1365-2133

Publication Date

December 2020

Volume

183

Issue

6

Start / End Page

1105 / 1107

Location

England

Related Subject Headings

  • Protein Kinase Inhibitors
  • Phosphoproteins
  • Humans
  • ErbB Receptors
  • Dermatology & Venereal Diseases
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vasavda, C., Ho, B. K., Zhang, D. Y., Williams, K. A., Kaffenberger, B. H., Kwatra, S. G., & Kwatra, M. M. (2020). First- and third-generation epidermal growth factor receptor inhibitors mediate distinct phosphoprotein signalling networks: implications for adverse dermatological reactions. Br J Dermatol, 183(6), 1105–1107. https://doi.org/10.1111/bjd.19263
Vasavda, C., B. K. Ho, D. Y. Zhang, K. A. Williams, B. H. Kaffenberger, S. G. Kwatra, and M. M. Kwatra. “First- and third-generation epidermal growth factor receptor inhibitors mediate distinct phosphoprotein signalling networks: implications for adverse dermatological reactions.Br J Dermatol 183, no. 6 (December 2020): 1105–7. https://doi.org/10.1111/bjd.19263.
Vasavda C, Ho BK, Zhang DY, Williams KA, Kaffenberger BH, Kwatra SG, et al. First- and third-generation epidermal growth factor receptor inhibitors mediate distinct phosphoprotein signalling networks: implications for adverse dermatological reactions. Br J Dermatol. 2020 Dec;183(6):1105–7.
Vasavda C, Ho BK, Zhang DY, Williams KA, Kaffenberger BH, Kwatra SG, Kwatra MM. First- and third-generation epidermal growth factor receptor inhibitors mediate distinct phosphoprotein signalling networks: implications for adverse dermatological reactions. Br J Dermatol. 2020 Dec;183(6):1105–1107.
Journal cover image

Published In

Br J Dermatol

DOI

EISSN

1365-2133

Publication Date

December 2020

Volume

183

Issue

6

Start / End Page

1105 / 1107

Location

England

Related Subject Headings

  • Protein Kinase Inhibitors
  • Phosphoproteins
  • Humans
  • ErbB Receptors
  • Dermatology & Venereal Diseases
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences